The global wound care market size is projected to showcase significant progress and earn USD 24.55 billion by 2027. This is accountable to the increasing prevalence of chronic diseases such as diabetes, blood pressure, and the wounds that result from them, such as diabetic foot ulcers and pressure ulcers. Wound care is used for injuries that are unable to heal by themselves. If untreated, they may result in severe consequences, such as mobility issues, decreased elasticity of blood vessels, and others. A recent report by Fortune Business Insights offers an elaborative overview of the market. The report is titled, “Wound Care Market Size, Share & Covid-19 Impact Analysis, By Type (Advanced Wound Dressing, Traditional Wound Care Products, Negative Pressure Wound Therapy, Bioactives, and Others), By Application (Chronic Wounds, and Acute Wounds), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Regional Forecast, 2020-2027.” According to this report, the market value stood at USD 15.68 billion in 2019 and is likely to exhibit a CAGR of 6.0% between 2020 to 2027.

Please visit: https://www.fortunebusinessinsights.com/wound-care-market-103268

As per a report by Fortune Business Insights™, some of the significant players in the market are as follows:

Johnson & Johnson Services, Inc.
Smith & Nephew
Coloplast Corp
Cardinal Health
ConvaTec Inc.
Medtronic
3M
BSN Medical (Essity)
PAUL HARTMANN AG
Other players
Increasing Popularity of Bioactive Therapy to Add Impetus to Market

The rising prevalence of acute and chronic diseases such as diabetic foot ulcers, pressure ulcers, and others are some of the key factors promoting this market growth. This, coupled with the advent and adoption of technologically advanced wound care products, will also add impetus to the market. Additionally, continuous research and development, as well as increasing investments in the launch of advanced wound care products are likely to bolster growth in the coming years.

On the contrary, high treatment costs and the presence of limited or no reimbursement policies, especially in the underdeveloped nations, may challenge the growth of the market. Nevertheless, the advent of bioactive therapy for treating chronic wounds is expected to create a lucrative growth opportunity for the market in the coming years.

Advanced Wound Dressing Segment to earn Largest Share Owing to Better Product Offering

Based on segmentation by type, the advanced wound dressing segment earned 42.6% wound care market share in 2019 and emerged dominant. This is owing to the presence of a diverse product portfolio.